Related Experiment Video
Updated: Apr 28, 2026

Anti-virulent Disruption of Pathogenic Biofilms using Engineered Quorum-quenching Lactonases
Published on: January 1, 2016
Quorum quenching agents: resources for antivirulence therapy
1College of Marine Life Sciences, Ocean University of China, Qingdao 266003, China. kaihao.tang@gmail.com.
Abstract:
The continuing emergence of antibiotic-resistant pathogens is a concern to human health and highlights the urgent need for the development of alternative therapeutic strategies. Quorum sensing (QS) regulates virulence in many bacterial pathogens, and thus, is a promising target for antivirulence therapy which may inhibit virulence instead of cell growth and division. This means that there is little selective pressure for the evolution of resistance. Many natural quorum quenching (QQ) agents have been identified. Moreover, it has been shown that many microorganisms are capable of producing small molecular QS inhibitors and/or macromolecular QQ enzymes, which could be regarded as a strategy for bacteria to gain benefits in competitive environments. More than 30 species of marine QQ bacteria have been identified thus far, but only a few of them have been intensively studied. Recent studies indicate that an enormous number of QQ microorganisms are undiscovered in the highly diverse marine environments, and these marine microorganism-derived QQ agents may be valuable resources for antivirulence therapy.
Insights
Antibiotic resistance is a growing threat. Marine microorganisms offer promising natural quorum quenching (QQ) agents as novel antivirulence therapies, targeting bacterial communication without promoting resistance.
Area of Science:
- Microbiology
- Marine Biotechnology
- Drug Discovery
Background:
- Emerging antibiotic-resistant pathogens pose a significant threat to human health.
- Quorum sensing (QS) controls virulence in many bacteria, making it a key target for antivirulence strategies.
- Antivirulence therapies offer an alternative by inhibiting virulence rather than cell growth, reducing resistance evolution.
Purpose of the Study:
- To highlight the potential of quorum quenching (QQ) agents derived from marine microorganisms as a therapeutic strategy.
- To underscore the untapped potential of marine environments for discovering novel QQ agents.
- To emphasize the value of marine microorganism-derived QQ agents for developing new antivirulence therapies.
Main Methods:
- Review of existing literature on quorum sensing (QS) and quorum quenching (QQ) mechanisms.
- Identification and analysis of known marine QQ bacteria and their derived agents.
- Exploration of the diversity of marine microbial communities as a source for novel QQ agents.
Main Results:
- Quorum quenching (QQ) agents, produced by microorganisms, can inhibit bacterial virulence.
- Marine environments harbor a vast, largely unexplored diversity of QQ microorganisms.
- Over 30 species of marine QQ bacteria have been identified, though few are well-studied.
Conclusions:
- Marine microorganism-derived QQ agents represent a valuable, underexplored resource for developing novel antivirulence therapies.
- Targeting bacterial QS offers a promising avenue to combat antibiotic resistance.
- Further research into marine QQ agents is crucial for advancing therapeutic strategies against resistant pathogens.
Related Concept Videos
Gene Regulation in Microbial Communities: Quorum Sensing
Inhibitors of Viral Protein Synthesis
Inhibitors of Bacterial DNA Synthesis
Chemical Agents for Microbial Control
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Subviral Agents

